{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:17:30Z","timestamp":1790626650727,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62306051"],"award-info":[{"award-number":["62306051"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62481540175"],"award-info":[{"award-number":["62481540175"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801740"],"award-info":[{"award-number":["81801740"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Program of China","award":["2022YFC2503804"],"award-info":[{"award-number":["2022YFC2503804"]}]},{"name":"Science and Technology Innovation Program of Hunan Province","award":["2021RC4056"],"award-info":[{"award-number":["2021RC4056"]}]},{"name":"clinical research foundation of the National Clinical Research Center for Geriatric Diseases","award":["2020LNJJ01"],"award-info":[{"award-number":["2020LNJJ01"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M723561"],"award-info":[{"award-number":["2022M723561"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["NJ2022028"],"award-info":[{"award-number":["NJ2022028"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Scientific and the Technological Research Program of Chongqing Municipal Education Commission","award":["KJQN202300718"],"award-info":[{"award-number":["KJQN202300718"]}]},{"name":"Clinical Research Foundation of the National Clinical Research Center for Geriatric Diseases","award":["2023LNJJ16"],"award-info":[{"award-number":["2023LNJJ16"]}]},{"DOI":"10.13039\/501100019092","name":"Science Fund for Distinguished Young Scholars of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ2094"],"award-info":[{"award-number":["2024JJ2094"]}],"id":[{"id":"10.13039\/501100019092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013277","name":"National Clinical Key Specialty Project Foundation","doi-asserted-by":"publisher","award":["Z2023004"],"award-info":[{"award-number":["Z2023004"]}],"id":[{"id":"10.13039\/501100013277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2020JJ5922"],"award-info":[{"award-number":["2020JJ5922"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2021JJ31060"],"award-info":[{"award-number":["2021JJ31060"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00259-024-07065-2","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T03:38:09Z","timestamp":1737949089000},"page":"2063-2075","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["PSMA PET\/CT based multimodal deep learning model for accurate prediction of pelvic lymph-node metastases in prostate cancer patients identified as candidates for extended pelvic lymph node dissection by preoperative nomograms"],"prefix":"10.1007","volume":"52","author":[{"given":"Qiaoke","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Rominger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuangyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0998-8943","authenticated-orcid":false,"given":"Shuo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"7065_CR1","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S1470-2045(06)70700-8","volume":"7","author":"EM Messing","year":"2006","unstructured":"Messing EM, Manola J, Yao J, Kiernan M, Crawford D, Wilding G, et al. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol. 2006;7:472\u20139. https:\/\/doi.org\/10.1016\/S1470-2045(06)70700-8.","journal-title":"Lancet Oncol"},{"key":"7065_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.eururo.2018.04.017","volume":"74","author":"F Abdollah","year":"2018","unstructured":"Abdollah F, Dalela D, Sood A, Keeley J, Alanee S, Briganti A, et al. Impact of Adjuvant Radiotherapy in Node-positive prostate Cancer patients: the importance of patient selection. Eur Urol. 2018;74:253\u20136. https:\/\/doi.org\/10.1016\/j.eururo.2018.04.017.","journal-title":"Eur Urol"},{"key":"7065_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/bju.14241","volume":"123","author":"M Gupta","year":"2019","unstructured":"Gupta M, Patel HD, Schwen ZR, Tran PT, Partin AW. Adjuvant radiation with androgen-deprivation therapy for men with lymph node metastases after radical prostatectomy: identifying men who benefit. BJU Int. 2019;123:252\u201360. https:\/\/doi.org\/10.1111\/bju.14241.","journal-title":"BJU Int"},{"key":"7065_CR4","doi-asserted-by":"publisher","unstructured":"Fossati N, Willemse P-PM, Van den Broeck T, van den Bergh RCN, Yuan CY, Briers E, et al. The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review. Eur Urol. 2017;72. https:\/\/doi.org\/10.1016\/j.eururo.2016.12.003.","DOI":"10.1016\/j.eururo.2016.12.003"},{"key":"7065_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.eururo.2020.11.040","volume":"79","author":"JFP Lestingi","year":"2021","unstructured":"Lestingi JFP, Guglielmetti GB, Trinh Q-D, Coelho RF, Pontes J, Bastos DA, et al. Extended Versus Limited Pelvic Lymph Node Dissection during Radical Prostatectomy for Intermediate- and high-risk prostate Cancer: early oncological outcomes from a Randomized Phase 3 Trial. Eur Urol. 2021;79:595\u2013604. https:\/\/doi.org\/10.1016\/j.eururo.2020.11.040.","journal-title":"Eur Urol"},{"key":"7065_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.03.027","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2024. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.027.","journal-title":"Eur Urol"},{"key":"7065_CR7","unstructured":"MSKCC Pre-Radical Prostatectomy [Internet]. Available from: https:\/\/www.mskcc.org\/nomograms\/prostate\/pre_op"},{"key":"7065_CR8","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.eururo.2017.03.049","volume":"72","author":"G Gandaglia","year":"2017","unstructured":"Gandaglia G, Fossati N, Zaffuto E, Bandini M, Dell\u2019Oglio P, Bravi CA, et al. Development and Internal Validation of a Novel Model to identify the candidates for extended pelvic lymph node dissection in prostate Cancer. Eur Urol. 2017;72:632\u201340. https:\/\/doi.org\/10.1016\/j.eururo.2017.03.049.","journal-title":"Eur Urol"},{"key":"7065_CR9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.eururo.2018.10.012","volume":"75","author":"G Gandaglia","year":"2019","unstructured":"Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Fossati N, et al. A Novel Nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate Cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies. Eur Urol. 2019;75:506\u201314. https:\/\/doi.org\/10.1016\/j.eururo.2018.10.012.","journal-title":"Eur Urol"},{"key":"7065_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.eururo.2023.03.001","volume":"84","author":"KM Chow","year":"2023","unstructured":"Chow KM, So WZ, Lee HJ, Lee A, Yap DWT, Takwoingi Y, et al. Head-to-head comparison of the diagnostic accuracy of prostate-specific membrane Antigen Positron Emission Tomography and Conventional Imaging modalities for initial staging of Intermediate- to high-risk prostate Cancer: a systematic review and Meta-analysis. Eur Urol. 2023;84:36\u201348. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.001.","journal-title":"Eur Urol"},{"key":"7065_CR11","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","volume":"395","author":"MS Hofman","year":"2020","unstructured":"Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet (London England). 2020;395:1208\u201316. https:\/\/doi.org\/10.1016\/S0140-6736(20)30314-7.","journal-title":"Lancet (London England)"},{"key":"7065_CR12","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1001\/jamaoncol.2021.3771","volume":"7","author":"TA Hope","year":"2021","unstructured":"Hope TA, Eiber M, Armstrong WR, Juarez R, Murthy V, Lawhn-Heath C, et al. Diagnostic accuracy of 68Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: a multicenter prospective phase 3 imaging trial. JAMA Oncol. 2021;7:1635\u201342. https:\/\/doi.org\/10.1001\/jamaoncol.2021.3771.","journal-title":"JAMA Oncol"},{"key":"7065_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/JU.0000000000001698","volume":"206","author":"KJ Pienta","year":"2021","unstructured":"Pienta KJ, Gorin MA, Rowe SP, Carroll PR, Pouliot F, Probst S, et al. A phase 2\/3 prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET\/CT with 18F-DCFPyL in prostate Cancer patients (OSPREY). J Urol. 2021;206:52\u201361. https:\/\/doi.org\/10.1097\/JU.0000000000001698.","journal-title":"J Urol"},{"key":"7065_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"M Perera","year":"2020","unstructured":"Perera M, Papa N, Roberts M, Williams M, Udovicich C, Vela I, et al. Gallium-68 prostate-specific membrane Antigen Positron Emission Tomography in Advanced prostate Cancer-updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane Antigen-avid lesions: a systematic review and Meta-analysis. Eur Urol. 2020;77:403\u201317. https:\/\/doi.org\/10.1016\/j.eururo.2019.01.049.","journal-title":"Eur Urol"},{"key":"7065_CR15","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00259-017-3631-6","volume":"44","author":"C Uprimny","year":"2017","unstructured":"Uprimny C, Kroiss AS, Decristoforo C, Fritz J, von Guggenberg E, Kendler D, et al. 68Ga-PSMA-11 PET\/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour. Eur J Nucl Med Mol Imaging. 2017;44:941\u20139. https:\/\/doi.org\/10.1007\/s00259-017-3631-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7065_CR16","first-page":"6357","volume":"9","author":"JS Ross","year":"2003","unstructured":"Ross JS, Sheehan CE, Fisher HAG, Kaufman RP, Kaur P, Gray K, et al. Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Clin Cancer Research: Official J Am Association Cancer Res. 2003;9:6357\u201362.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"key":"7065_CR17","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s13139-017-0476-7","volume":"51","author":"C-AJ von Klot","year":"2017","unstructured":"von Klot C-AJ, Merseburger AS, B\u00f6ker A, Schmuck S, Ross TL, Bengel FM, et al. 68Ga-PSMA PET\/CT Imaging Predicting Intraprostatic Tumor Extent, Extracapsular extension and seminal vesicle Invasion Prior to Radical Prostatectomy in patients with prostate Cancer. Nucl Med Mol Imaging. 2017;51:314\u201322. https:\/\/doi.org\/10.1007\/s13139-017-0476-7.","journal-title":"Nucl Med Mol Imaging"},{"key":"7065_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00259-019-04511-4","volume":"47","author":"DA Ferraro","year":"2020","unstructured":"Ferraro DA, Muehlematter UJ, Garcia Sch\u00fcler HI, Rupp NJ, Huellner M, Messerli M, et al. 68Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer. Eur J Nucl Med Mol Imaging. 2020;47:147\u201359. https:\/\/doi.org\/10.1007\/s00259-019-04511-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7065_CR19","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/pros.24415","volume":"82","author":"Y Wang","year":"2022","unstructured":"Wang Y, Tang Y, Gao X, Gan Y, Hu S, Chen M-F, et al. Optimization of prostate cancer patient lymph node staging via the integration of neutrophil-lymphocyte ratios, platelet-lymphocyte ratios, and 68 Ga-PSMA-PET-derived SUVmax values. Prostate. 2022;82:1415\u201321. https:\/\/doi.org\/10.1002\/pros.24415.","journal-title":"Prostate"},{"key":"7065_CR20","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1097\/JU.0000000000001201","volume":"204","author":"A Kanthabalan","year":"2020","unstructured":"Kanthabalan A, Arya M, Freeman A, Mitra AV, Payne H, Peters M, et al. Intraprostatic Cancer recurrence following Radical Radiotherapy on Transperineal Template Mapping Biopsy: implications for focal ablative salvage therapy. J Urol. 2020;204:950\u20135. https:\/\/doi.org\/10.1097\/JU.0000000000001201.","journal-title":"J Urol"},{"key":"7065_CR21","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.eururo.2014.08.079","volume":"67","author":"JD Le","year":"2015","unstructured":"Le JD, Tan N, Shkolyar E, Lu DY, Kwan L, Marks LS, et al. Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. Eur Urol. 2015;67:569\u201376. https:\/\/doi.org\/10.1016\/j.eururo.2014.08.079.","journal-title":"Eur Urol"},{"key":"7065_CR22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41568-018-0016-5","volume":"18","author":"A Hosny","year":"2018","unstructured":"Hosny A, Parmar C, Quackenbush J, Schwartz LH, Aerts HJWL. Artificial intelligence in radiology. Nat Rev Cancer. 2018;18:500\u201310. https:\/\/doi.org\/10.1038\/s41568-018-0016-5.","journal-title":"Nat Rev Cancer"},{"key":"7065_CR23","doi-asserted-by":"publisher","first-page":"7513","DOI":"10.1038\/s41467-023-42811-4","volume":"14","author":"Y Zhong","year":"2023","unstructured":"Zhong Y, Cai C, Chen T, Gui H, Deng J, Yang M, et al. PET\/CT based cross-modal deep learning signature to predict occult nodal metastasis in lung cancer. Nat Commun. 2023;14:7513. https:\/\/doi.org\/10.1038\/s41467-023-42811-4.","journal-title":"Nat Commun"},{"key":"7065_CR24","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1097\/JS9.0000000000000469","volume":"109","author":"N Fu","year":"2023","unstructured":"Fu N, Fu W, Chen H, Chai W, Qian X, Wang W, et al. A deep-learning radiomics-based lymph node metastasis predictive model for pancreatic cancer: a diagnostic study. Int J Surg. 2023;109:2196\u2013203. https:\/\/doi.org\/10.1097\/JS9.0000000000000469.","journal-title":"Int J Surg"},{"key":"7065_CR25","doi-asserted-by":"publisher","first-page":"102385","DOI":"10.1016\/j.eclinm.2023.102385","volume":"67","author":"W Wang","year":"2024","unstructured":"Wang W, Liang H, Zhang Z, Xu C, Wei D, Li W, et al. Comparing three-dimensional and two-dimensional deep-learning, radiomics, and fusion models for predicting occult lymph node metastasis in laryngeal squamous cell carcinoma based on CT imaging: a multicentre, retrospective, diagnostic study. EClinicalMedicine. 2024;67:102385. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102385.","journal-title":"EClinicalMedicine"},{"key":"7065_CR26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00259-019-04606-y","volume":"47","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Gafita A, Vollnberg B, Tetteh G, Haupt F, Afshar-Oromieh A, et al. Deep neural network for automatic characterization of lesions on 68Ga-PSMA-11 PET\/CT. Eur J Nucl Med Mol Imaging. 2020;47:603\u201313. https:\/\/doi.org\/10.1007\/s00259-019-04606-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7065_CR27","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1007\/s00259-022-05806-9","volume":"49","author":"E Tr\u00e4g\u00e5rdh","year":"2022","unstructured":"Tr\u00e4g\u00e5rdh E, Enqvist O, Ul\u00e9n J, Hvittfeldt E, Garpered S, Belal SL, et al. Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians. Eur J Nucl Med Mol Imaging. 2022;49:3412\u20138. https:\/\/doi.org\/10.1007\/s00259-022-05806-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7065_CR28","doi-asserted-by":"publisher","unstructured":"Tr\u00e4g\u00e5rdh E, Enqvist O, Ul\u00e9n J, J\u00f6gi J, Bitz\u00e9n U, Hedeer F, et al. Freely available, fully automated AI-based analysis of primary tumour and metastases of prostate cancer in whole-body [18F]-PSMA-1007 PET-CT. Diagnostics (Basel). 2022;12. https:\/\/doi.org\/10.3390\/diagnostics12092101.","DOI":"10.3390\/diagnostics12092101"},{"key":"7065_CR29","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.euo.2023.05.003","volume":"6","author":"G Gandaglia","year":"2023","unstructured":"Gandaglia G, Barletta F, Robesti D, Scuderi S, Rajwa P, Gomez Rivas J, et al. Identification of the optimal candidates for nodal staging with extended pelvic lymph node dissection among prostate Cancer patients who underwent preoperative prostate-specific membrane Antigen Positron Emission Tomography. External validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool. Eur Urol Oncol. 2023;6:543\u201352. https:\/\/doi.org\/10.1016\/j.euo.2023.05.003.","journal-title":"Eur Urol Oncol"},{"key":"7065_CR30","doi-asserted-by":"publisher","unstructured":"van Leenders GJLH, van der Kwast TH, Iczkowski KA. The 2019 international society of urological pathology consensus conference on prostate cancer grading. European Urology. 2021;79:707-9. https:\/\/doi.org\/10.1016\/j.eururo.2020.08.004","DOI":"10.1016\/j.eururo.2020.08.004"},{"key":"7065_CR31","doi-asserted-by":"publisher","unstructured":"Werner RA, Hartrampf PE, Fendler WP, Serfling SE, Derlin T, Higuchi T, et al. Prostate-specific membrane antigen reporting and data system version 2.0. Eur Urol. 2023;84:491\u2013502. https:\/\/doi.org\/10.1016\/j.eururo.2023.06.008.","DOI":"10.1016\/j.eururo.2023.06.008"},{"key":"7065_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.eururo.2023.02.002","volume":"83","author":"R Seifert","year":"2023","unstructured":"Seifert R, Emmett L, Rowe SP, Herrmann K, Hadaschik B, Calais J, et al. Second Version of the prostate Cancer molecular imaging standardized evaluation Framework including response evaluation for clinical trials (PROMISE V2). Eur Urol. 2023;83:405\u201312. https:\/\/doi.org\/10.1016\/j.eururo.2023.02.002.","journal-title":"Eur Urol"},{"key":"7065_CR33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.euo.2021.02.001","volume":"4","author":"GE Cacciamani","year":"2021","unstructured":"Cacciamani GE, Maas M, Nassiri N, Ortega D, Gill K, Dell\u2019Oglio P, et al. Impact of pelvic lymph node dissection and its extent on Perioperative Morbidity in patients undergoing radical prostatectomy for prostate Cancer: a comprehensive systematic review and Meta-analysis. Eur Urol Oncol. 2021;4:134\u201349. https:\/\/doi.org\/10.1016\/j.euo.2021.02.001.","journal-title":"Eur Urol Oncol"},{"key":"7065_CR34","unstructured":"Chen S, Ma K, Zheng Y. Transfer learning for 3d medical image analysis. arXiv Preprint arXiv:190400625; 2019."},{"key":"7065_CR35","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2021.05.006","volume":"80","author":"D Meijer","year":"2021","unstructured":"Meijer D, van Leeuwen PJ, Roberts MJ, Siriwardana AR, Morton A, Yaxley JW, et al. External validation and addition of prostate-specific membrane Antigen Positron Emission Tomography to the most frequently used nomograms for the prediction of pelvic lymph-node metastases: an International Multicenter Study. Eur Urol. 2021;80:234\u201342. https:\/\/doi.org\/10.1016\/j.eururo.2021.05.006.","journal-title":"Eur Urol"},{"key":"7065_CR36","doi-asserted-by":"publisher","first-page":"786","DOI":"10.2967\/jnumed.118.219501","volume":"60","author":"TA Hope","year":"2019","unstructured":"Hope TA, Goodman JZ, Allen IE, Calais J, Fendler WP, Carroll PR. Metaanalysis of 68Ga-PSMA-11 PET accuracy for the detection of prostate Cancer validated by histopathology. J Nuclear Medicine: Official Publication Soc Nuclear Med. 2019;60:786\u201393. https:\/\/doi.org\/10.2967\/jnumed.118.219501.","journal-title":"J Nuclear Medicine: Official Publication Soc Nuclear Med"},{"key":"7065_CR37","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.2967\/jnumed.117.207696","volume":"59","author":"M Thalgott","year":"2018","unstructured":"Thalgott M, D\u00fcwel C, Rauscher I, Heck MM, Haller B, Gafita A, et al. One-stop-shop whole-body 68Ga-PSMA-11 PET\/MRI compared with clinical nomograms for preoperative T and N staging of high-risk prostate Cancer. J Nuclear Medicine: Official Publication Soc Nuclear Med. 2018;59:1850\u20136. https:\/\/doi.org\/10.2967\/jnumed.117.207696.","journal-title":"J Nuclear Medicine: Official Publication Soc Nuclear Med"},{"key":"7065_CR38","doi-asserted-by":"publisher","unstructured":"Stabile A, Pellegrino A, Mazzone E, Cannoletta D, de Angelis M, Barletta F, et al. Can negative prostate-specific membrane antigen positron emission tomography\/computed tomography avoid the need for pelvic lymph node dissection in newly diagnosed prostate cancer patients? A systematic review and meta-analysis with backup histology as reference standard. Eur Urol Oncol. 2022;5. https:\/\/doi.org\/10.1016\/j.euo.2021.08.001.","DOI":"10.1016\/j.euo.2021.08.001"},{"key":"7065_CR39","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1007\/s00259-023-06278-1","volume":"50","author":"UJ Muehlematter","year":"2023","unstructured":"Muehlematter UJ, Schweiger L, Ferraro DA, Hermanns T, Maurer T, Heck MM, et al. Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer. Eur J Nucl Med Mol Imaging. 2023;50:3137\u201346. https:\/\/doi.org\/10.1007\/s00259-023-06278-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7065_CR40","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.euo.2023.03.010","volume":"6","author":"AN Vis","year":"2023","unstructured":"Vis AN, Meijer D, Roberts MJ, Siriwardana AR, Morton A, Yaxley JW, et al. Development and External Validation of a Novel Nomogram to predict the probability of pelvic lymph-node metastases in prostate Cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane Antigen Positron Emission Tomography. Eur Urol Oncol. 2023;6:553\u201363. https:\/\/doi.org\/10.1016\/j.euo.2023.03.010.","journal-title":"Eur Urol Oncol"},{"key":"7065_CR41","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00259-020-04971-z","volume":"48","author":"MCF Cysouw","year":"2021","unstructured":"Cysouw MCF, Jansen BHE, van de Brug T, Oprea-Lager DE, Pfaehler E, de Vries BM, et al. Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer. Eur J Nucl Med Mol Imaging. 2021;48:340\u20139. https:\/\/doi.org\/10.1007\/s00259-020-04971-z.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-07065-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-024-07065-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-07065-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T10:27:03Z","timestamp":1745317623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-024-07065-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["7065"],"URL":"https:\/\/doi.org\/10.1007\/s00259-024-07065-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Institutional Review Board of Xiangya Hospital, Central South University and the requirement for written informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Robert Seifert has received research\/travel support from the Boehringer Ingelheim Fund and the Else Kr\u00f6ner-Fresenius-Stiftung, as well as travel support and lecture fees from Novartis and Boston Scientific outside the submitted work. The other authors declare that no competing interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}